Reaction #68047
ord-473148dd016b4c6ba71b60824cefb0a1
Reaction equation
Reactants
Reagents
Solvents
Conditions
Workup
- 1workup.ADDITIONwas added
- 2OtherThe solvent was removed under reduced pressure, and aqueous saturated sodium hydrogen carbonate solution and chloroform
- 3workup.ADDITIONwere added
- 4OtherThe organic layer was separated
- 5Extractionthe aqueous layer was extracted with chloroform
- 6Washwashed with aqueous saturated sodium chloride solution
- 7Dryingdried over anhydrous magnesium sulfate
- 8Otherthe solvent was removed under reduced pressure
- 9OtherThe residue thus obtained
- 10Otherwas purified by silica gel column chromatography [eluent; chloroform:methanol=10:1]
Procedure
To 2 mL of a chloroform solution containing 0.25 g of methyl 1-(2-(4-((tert-butoxycarbonyl)(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-7-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate, 2 mL of trifluoroacetic acid was added and stirred for 16 hours. The solvent was removed under reduced pressure, and aqueous saturated sodium hydrogen carbonate solution and chloroform were added. The organic layer was separated, and the aqueous layer was extracted with chloroform. The organic layer and extracts were combined, washed with aqueous saturated sodium chloride solution, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue thus obtained was purified by silica gel column chromatography [eluent; chloroform:methanol=10:1] to give 0.12 g of methyl 1-(2-(4-((2,3-dihydro-1,4-benzodioxin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-7-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate as a white solid.